Eagle Pharmaceuticals, Inc. to Present at 36th Annual J.P. Morgan Healthcare Conference

Tuesday, January 2, 2018 6:50 am EST

Dateline:

WOODCLIFF LAKE, N.J.

Public Company Information:

NASDAQ:
EGRX

WOODCLIFF LAKE, N.J.--(BUSINESS WIRE)--Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (“Eagle” or “the Company”) today announced that Scott Tarriff, Chief Executive Officer, and Pete Meyers, Chief Financial Officer, will present at the 36th Annual J.P Morgan Healthcare Conference as follows:

Date:    

Wednesday, January 10, 2018

   
Time:

4:30 p.m. Pacific Standard Time

Location: Westin St. Francis Hotel, San Francisco

Webcast:

https://jpmorgan.metameetings.net/events/healthcare18/sessions/13395-eagle-pharmaceuticals/webcast

 

The presentation will be webcast live at the aforementioned time, and archived for 30 days thereafter, via the Company’s website at www.eagleus.com, under the Investors Section.

About Eagle Pharmaceuticals, Inc.

Eagle is a specialty pharmaceutical company focused on developing and commercializing injectable products that address the shortcomings, as identified by physicians, pharmacists and other stakeholders, of existing commercially successful injectable products. Eagle’s strategy is to utilize the FDA's 505(b)(2) regulatory pathway. Additional information is available on the Company’s website at www.eagleus.com.

Contact:

Investor Relations for Eagle Pharmaceuticals, Inc:
Lisa M. Wilson, 212-452-2793
lwilson@insitecony.com